Siemens Healthineers will co-lead a European research project dedicated to improving the diagnosis, treatment, and monitoring of Alzheimer’s disease.
The five-year project, called ACCESS-AD, launches this month and aims to create a collaborative, patient-centered strategy for Alzheimer’s care. The project unites more than 30 European partners from hospitals, universities, patient organizations, and industry, representing expertise in neurology, imaging, data science, and patient advocacy, Siemens said.
ACCESS-AD will standardize procedures, integrate state-of-the-art industry technology, and leverage AI for advanced disease management, the company said. This includes analyzing medical scans, blood tests, and digital health data, which can help predict treatment responses and identify patients at higher risk of complications.
The project team will collect real-world data from more than 500 patients across Europe and is running a pilot study to test combinations of drug therapies and lifestyle interventions for Alzheimer’s care, Siemens noted.
